secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001612630-24-000003
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Joint Corp Q1 rev $29.7M (+5% YoY), operating income $1.1M, reiterates guidance
-------------------------------------------------------------------------------

- Revenue $29.7M (+5% YoY); operating income $1.1M vs loss $653k; net income $0.06/diluted share.
- Adjusted EBITDA $3.5M (+75% from $2.0M); system-wide comp sales +3%.
- Opened 23 franchised clinics; total clinic count 954; sold 15 franchise licenses, triple Q4 2023's 5.
- FY 2024 guidance reiterated: system-wide sales $530-545M, new franchised openings 60-75 (excl. refranchising).
- Hired investment bank specializing in refranchising to accelerate corporate clinic portfolio transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000161263024000003/0001612630-24-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000161263024000003/jynt-20240502.htm
  HTML page:      https://secwatch.observer/filing/0001612630-24-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer